{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:21Z","timestamp":1792686201542,"version":"4.5.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8508","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T18:14:11Z","timestamp":1501524851000},"page":"1977-1980","source":"Crossref","is-referenced-by-count":18,"title":["Dabigatran Therapy Resulting in the Resolution of Rivaroxaban-resistant Left Atrial Appendage Thrombi in Patients with Atrial Fibrillation"],"prefix":"10.2169","volume":"56","author":[{"given":"Tetsuya","family":"Watanabe","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Shinoda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Ikeoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Minamisaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetada","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirooki","family":"Inui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Hoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Yao Municipal Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with nonvalvular atrial fibrillation: a retrospective study. Stroke 14: 688-693, 1983.","DOI":"10.1161\/01.STR.14.5.688"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Atrial fibrillation: current understandings and research imperatives. The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. J Am Coll Cardiol 22: 1830-1834, 1993.","DOI":"10.1016\/0735-1097(93)90765-S"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343: 687-691, 1994.","DOI":"10.1016\/S0140-6736(94)92123-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361: 1139-1151, 2009.","DOI":"10.1056\/NEJMoa0905561"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365: 883-891, 2011.","DOI":"10.1056\/NEJMoa1009638"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365: 981-992, 2011.","DOI":"10.1056\/NEJMoa1107039"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369: 2093-2104, 2013.","DOI":"10.1056\/NEJMoa1310907"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ellis K, Ziada KM, Vivekananthan D, et al. Transthoracic echocardiographic predictors of left atrial appendage thrombus. Am J Cardiol 97: 421-425, 2006.","DOI":"10.1016\/j.amjcard.2005.08.065"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Leung DY, Davidson PM, Cranney GB, Walsh WF. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram. Am J Cardiol 79: 626-629, 1997.","DOI":"10.1016\/S0002-9149(96)00828-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsai LM, Lin LJ, Teng JK, Chen JH. Prevalence and clinical significance of left atrial thrombus in nonrheumatic atrial fibrillation. Int J Cardiol 58: 163-169, 1997.","DOI":"10.1016\/S0167-5273(96)02862-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stoddard MF, Singh P, Dawn B, Longaker RA. Left atrial thrombus predicts transient ischemic attack in patients with atrial fibrillation. Am Heart J 145: 676-682, 2003.","DOI":"10.1067\/mhj.2003.91"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Thambidorai SK, Murray RD, Parakh K, et al. Utility of transesophageal echocardiography in identification of thrombogenic milieu in patients with atrial fibrillation (an ACUTE ancillary study). Am J Cardiol 96: 935-941, 2005.","DOI":"10.1016\/j.amjcard.2005.05.051"},{"key":"13","unstructured":"13. Kimura M, Wasaki Y, Ogawa H, et al. Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Jpn Circ J 65: 271-274, 2001."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Watanabe T, Shinoda Y, Ikeoka K, et al. Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin. Heart Vessels 2016 (Epub ahead of print).","DOI":"10.1007\/s00380-016-0871-5"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Corrado G, Tadeo G, Beretta S, et al. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation. Chest 115: 140-143, 1999.","DOI":"10.1378\/chest.115.1.140"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 353: 1028-1040, 2005.","DOI":"10.1056\/NEJMra044440"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ieko M, Naitoh S, Yoshida M, Takahashi N. Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences. J Intensive Care 4: 19, 2016.","DOI":"10.1186\/s40560-016-0144-5"},{"key":"18","unstructured":"18. Galanis T, Keiffer G, Merli G. The new oral anticoagulants for the treatment of venous thromboembolism: a new paradigm shift in antithrombotic therapy. Curr Ther Res Clin Exp 76: 76-83, 2014."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/15\/56_56.8508\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T13:18:48Z","timestamp":1659273528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/15\/56_56.8508\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8508","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}